Imprimis Receives FDA Warning Over Eye Medication Advertising

The U.S. Food and Drug Administration has issued a warning letter to Imprimis Pharmaceuticals Inc accusing it of making false or misleading claims that its compounded eye medications had the agency's approval.
Reuters Health Information

Full Story →